09:51 AM EST - Titan Medical Inc. : Announced financial results for the three months ended March 31, 2018. Research and development expenses for the first quarter of 2018 were $3,274,074 compared with $2,946,323. Net and comprehensive loss for the first quarter of 2018 was $808,699, compared with a net and comprehensive loss of $4,988,274. Titan Medical Inc.
shares T.TMD are trading unchanged at $0.26.
